Adele K. Fielding

15.7k total citations · 6 hit papers
138 papers, 6.9k citations indexed

About

Adele K. Fielding is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Oncology. According to data from OpenAlex, Adele K. Fielding has authored 138 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Public Health, Environmental and Occupational Health, 78 papers in Hematology and 41 papers in Oncology. Recurrent topics in Adele K. Fielding's work include Acute Lymphoblastic Leukemia research (83 papers), Chronic Myeloid Leukemia Treatments (52 papers) and Childhood Cancer Survivors' Quality of Life (24 papers). Adele K. Fielding is often cited by papers focused on Acute Lymphoblastic Leukemia research (83 papers), Chronic Myeloid Leukemia Treatments (52 papers) and Childhood Cancer Survivors' Quality of Life (24 papers). Adele K. Fielding collaborates with scholars based in United Kingdom, United States and France. Adele K. Fielding's co-authors include Anthony H. Goldstone, Jacob M. Rowe, Martin S. Tallman, Georgina Buck, Mark R. Litzow, Andrew McMillan, David I. Marks, Selina M. Luger, Anthony V. Moorman and Hillard M. Lazarus and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Adele K. Fielding

134 papers receiving 6.8k citations

Hit Papers

Outcome of 609 adults after relapse of acute lymphoblasti... 2006 2026 2012 2019 2006 2007 2006 2017 2016 100 200 300 400 500

Peers

Adele K. Fielding
Comparison fields: 5 of 101
  • Public Health, Environmental and Occupational Health 3.9k
  • Hematology 3.8k
  • Oncology 2.2k
  • Pediatrics, Perinatology and Child Health 1.3k
  • Genetics 1.1k
Replace Peter Bader with:
Peter Bader Germany
Nancy Bunin United States
Salut Brunet Spain
Ephraim J. Fuchs United States
Patrice Chevallier France
Lan‐Ping Xu China
Max S. Topp Germany
George E. Sale United States
Paul Veys United Kingdom
Arjan C. Lankester Netherlands
Peter Bader Germany View profile →
Citations per field, relative to Adele K. Fielding
Adele K. Fielding · 1×
Citations per year, relative to Adele K. Fielding
Adele K. Fielding · 1×

Countries citing papers authored by Adele K. Fielding

Since Specialization
Citations

This map shows the geographic impact of Adele K. Fielding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adele K. Fielding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adele K. Fielding more than expected).

Fields of papers citing papers by Adele K. Fielding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adele K. Fielding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adele K. Fielding. The network helps show where Adele K. Fielding may publish in the future.

Co-authorship network of co-authors of Adele K. Fielding

This figure shows the co-authorship network connecting the top 25 collaborators of Adele K. Fielding. A scholar is included among the top collaborators of Adele K. Fielding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adele K. Fielding. Adele K. Fielding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 2
3 2
4 36
5 2
6 12
7
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study breakdown →
298
8 1
9 13
10
Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up breakdown →
291
11 22
12 15
13 57
14
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993) breakdown →
537
15
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial breakdown →
502
16 72
17 1
18 190
19 3
20 87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026